ATE553087T1 - Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel - Google Patents

Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel

Info

Publication number
ATE553087T1
ATE553087T1 AT04771118T AT04771118T ATE553087T1 AT E553087 T1 ATE553087 T1 AT E553087T1 AT 04771118 T AT04771118 T AT 04771118T AT 04771118 T AT04771118 T AT 04771118T AT E553087 T1 ATE553087 T1 AT E553087T1
Authority
AT
Austria
Prior art keywords
chronic obstructive
respiratory disease
group
obstructive respiratory
agent
Prior art date
Application number
AT04771118T
Other languages
English (en)
Inventor
Hidetsugu Takagaki
Yasuo Aoki
Mitsuteru Ishiwara
Nobuaki Mizutani
Original Assignee
Mariposa Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mariposa Health Ltd filed Critical Mariposa Health Ltd
Application granted granted Critical
Publication of ATE553087T1 publication Critical patent/ATE553087T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04771118T 2003-07-30 2004-07-27 Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel ATE553087T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003203699 2003-07-30
PCT/JP2004/011013 WO2005012251A1 (ja) 2003-07-30 2004-07-27 慢性閉塞性肺疾患治療剤及びそれを用いた慢性閉塞性肺疾患の治療方法

Publications (1)

Publication Number Publication Date
ATE553087T1 true ATE553087T1 (de) 2012-04-15

Family

ID=34113624

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04771118T ATE553087T1 (de) 2003-07-30 2004-07-27 Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel

Country Status (11)

Country Link
US (2) US8980914B2 (de)
EP (1) EP1650191B1 (de)
KR (1) KR101100659B1 (de)
CN (1) CN100422155C (de)
AT (1) ATE553087T1 (de)
AU (1) AU2004261527B2 (de)
CA (1) CA2533919C (de)
DK (1) DK1650191T3 (de)
ES (1) ES2382937T3 (de)
TW (1) TWI344365B (de)
WO (1) WO2005012251A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2943725B2 (ja) * 1996-01-17 1999-08-30 大日本インキ化学工業株式会社 キノリノン誘導体及びそれを有効成分とする抗アレルギー剤
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
TW430656B (en) 1997-12-03 2001-04-21 Dainippon Ink & Chemicals Quinolinone derivative, method for preparing the same, and anti-allergic agent
KR100908418B1 (ko) 2001-06-20 2009-07-21 액티버스 파마 컴퍼니 리미티드 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
EP1650191A1 (de) 2006-04-26
CN100422155C (zh) 2008-10-01
AU2004261527B2 (en) 2010-09-23
AU2004261527A1 (en) 2005-02-10
ES2382937T3 (es) 2012-06-14
US8980914B2 (en) 2015-03-17
CA2533919A1 (en) 2005-02-10
US20150157621A1 (en) 2015-06-11
US20060235045A1 (en) 2006-10-19
KR20060041286A (ko) 2006-05-11
CN1829693A (zh) 2006-09-06
TWI344365B (en) 2011-07-01
KR101100659B1 (ko) 2012-01-03
CA2533919C (en) 2010-10-12
DK1650191T3 (da) 2012-05-07
TW200509927A (en) 2005-03-16
WO2005012251A1 (ja) 2005-02-10
EP1650191B1 (de) 2012-04-11
EP1650191A4 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
MA28010A1 (fr) Derives de piperazine et leur utilisation comme agents therapeutiques
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
AR023957A1 (es) Pirazol carboxamidas utiles para el tratamiento de la obesidad y otros trastornos.
ATE361077T1 (de) Indanylderivate zur behandlung von atemwegserkrankungen
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
DE60332093D1 (de) Neues phenylalaninderivat
DE69521424D1 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
NO20045486L (no) Nye forbindelser og deres anvendelse
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20065060L (no) Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE325610T1 (de) Xanthinderivative zur behandlung von hirnischämie
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EP1637517A4 (de) 2-aminobicyclo¬3.1.0|hexan-2,6-dicarbonsäureesterderivat
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.